nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CASP3—cochlea—meningioma	0.0871	0.213	CbGeAlD
Minocycline—SLC22A8—choroid plexus—meningioma	0.0675	0.165	CbGeAlD
Minocycline—CYCS—pineal body—meningioma	0.0563	0.138	CbGeAlD
Minocycline—CASP1—Cellular roles of Anthrax toxin—PGR—meningioma	0.0304	0.0515	CbGpPWpGaD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—CST3—meningioma	0.0228	0.0386	CbGpPWpGaD
Minocycline—VEGFA—miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma —HES1—meningioma	0.0217	0.0366	CbGpPWpGaD
Minocycline—IL1B—Cellular roles of Anthrax toxin—PGR—meningioma	0.019	0.0322	CbGpPWpGaD
Minocycline—CYCS—brainstem—meningioma	0.0176	0.043	CbGeAlD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—CST3—meningioma	0.0158	0.0267	CbGpPWpGaD
Minocycline—CASP3—brainstem—meningioma	0.015	0.0368	CbGeAlD
Minocycline—MMP9—Osteopontin Signaling—PLAU—meningioma	0.0126	0.0213	CbGpPWpGaD
Minocycline—IL1B—brainstem—meningioma	0.012	0.0294	CbGeAlD
Minocycline—MMP9—Collagen degradation—CTSL—meningioma	0.0119	0.0201	CbGpPWpGaD
Minocycline—CASP1—spinal cord—meningioma	0.0113	0.0278	CbGeAlD
Minocycline—CYCS—spinal cord—meningioma	0.0109	0.0267	CbGeAlD
Minocycline—CASP3—medulla oblongata—meningioma	0.0105	0.0257	CbGeAlD
Minocycline—CASP3—spinal cord—meningioma	0.00935	0.0229	CbGeAlD
Minocycline—MMP9—Assembly of collagen fibrils and other multimeric structures—CTSL—meningioma	0.00923	0.0156	CbGpPWpGaD
Minocycline—CASP1—cerebellum—meningioma	0.00899	0.022	CbGeAlD
Minocycline—MMP9—amb2 Integrin signaling—PLAUR—meningioma	0.00875	0.0148	CbGpPWpGaD
Minocycline—CYCS—cerebellum—meningioma	0.00866	0.0212	CbGeAlD
Minocycline—CASP3—Degradation of the extracellular matrix—CTSL—meningioma	0.00865	0.0146	CbGpPWpGaD
Minocycline—IL1B—medulla oblongata—meningioma	0.00838	0.0205	CbGeAlD
Minocycline—VEGFA—S1P1 pathway—PDGFB—meningioma	0.00833	0.0141	CbGpPWpGaD
Minocycline—MMP9—Angiogenesis—PDGFB—meningioma	0.00796	0.0135	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAUR—meningioma	0.00779	0.0132	CbGpPWpGaD
Minocycline—IL1B—spinal cord—meningioma	0.00747	0.0183	CbGeAlD
Minocycline—CASP3—cerebellum—meningioma	0.00741	0.0182	CbGeAlD
Minocycline—VEGFA—spinal cord—meningioma	0.00735	0.018	CbGeAlD
Minocycline—CASP1—brain—meningioma	0.0073	0.0179	CbGeAlD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—HES1—meningioma	0.00721	0.0122	CbGpPWpGaD
Minocycline—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAUR—meningioma	0.00704	0.0119	CbGpPWpGaD
Minocycline—CYCS—brain—meningioma	0.00703	0.0172	CbGeAlD
Minocycline—VEGFA—Angiogenesis—PDGFB—meningioma	0.00691	0.0117	CbGpPWpGaD
Minocycline—VEGFA—S1P3 pathway—PDGFB—meningioma	0.00669	0.0113	CbGpPWpGaD
Minocycline—MMP9—Osteopontin-mediated events—PLAU—meningioma	0.00629	0.0106	CbGpPWpGaD
Minocycline—MMP9—Collagen formation—CTSL—meningioma	0.00629	0.0106	CbGpPWpGaD
Minocycline—MMP9—spinal cord—meningioma	0.00623	0.0152	CbGeAlD
Minocycline—MMP9—amb2 Integrin signaling—PLAU—meningioma	0.00614	0.0104	CbGpPWpGaD
Minocycline—CASP3—brain—meningioma	0.00602	0.0147	CbGeAlD
Minocycline—MMP9—Degradation of the extracellular matrix—CTSL—meningioma	0.00601	0.0102	CbGpPWpGaD
Minocycline—VEGFA—Beta3 integrin cell surface interactions—PLAUR—meningioma	0.00599	0.0101	CbGpPWpGaD
Minocycline—VEGFA—cerebellum—meningioma	0.00583	0.0143	CbGeAlD
Minocycline—MMP9—FGF signaling pathway—PLAUR—meningioma	0.00576	0.00973	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—meningioma	0.00546	0.00923	CbGpPWpGaD
Minocycline—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—meningioma	0.00494	0.00834	CbGpPWpGaD
Minocycline—IL1B—brain—meningioma	0.00481	0.0118	CbGeAlD
Minocycline—VEGFA—brain—meningioma	0.00473	0.0116	CbGeAlD
Minocycline—VEGFA—Signaling events mediated by TCPTP—PDGFB—meningioma	0.00459	0.00776	CbGpPWpGaD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—TP53—meningioma	0.00449	0.00758	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00433	0.00733	CbGpPWpGaD
Minocycline—VEGFA—Beta3 integrin cell surface interactions—PDGFB—meningioma	0.00433	0.00733	CbGpPWpGaD
Minocycline—VEGFA—Beta1 integrin cell surface interactions—PLAUR—meningioma	0.00426	0.00719	CbGpPWpGaD
Minocycline—VEGFA—Beta3 integrin cell surface interactions—PLAU—meningioma	0.00421	0.00711	CbGpPWpGaD
Minocycline—MMP9—FGF signaling pathway—PLAU—meningioma	0.00404	0.00682	CbGpPWpGaD
Minocycline—CASP3—Integrated Cancer Pathway—PTEN—meningioma	0.00404	0.00682	CbGpPWpGaD
Minocycline—MMP9—brain—meningioma	0.00401	0.00982	CbGeAlD
Minocycline—VEGFA—Differentiation Pathway—PDGFB—meningioma	0.00397	0.00671	CbGpPWpGaD
Minocycline—ALOX5—cerebellum—meningioma	0.0039	0.00956	CbGeAlD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00389	0.00658	CbGpPWpGaD
Minocycline—CYCS—Intrinsic Pathway for Apoptosis—TP53—meningioma	0.00384	0.00649	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—ERBB2—meningioma	0.00377	0.00638	CbGpPWpGaD
Minocycline—SLC22A7—brain—meningioma	0.00371	0.00908	CbGeAlD
Minocycline—CASP3—Extracellular matrix organization—CTSL—meningioma	0.00363	0.00613	CbGpPWpGaD
Minocycline—SLC22A6—brain—meningioma	0.00358	0.00877	CbGeAlD
Minocycline—CASP3—Copper homeostasis—PTEN—meningioma	0.00353	0.00597	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—PLAU—meningioma	0.00352	0.00596	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—PDGFB—meningioma	0.0035	0.00592	CbGpPWpGaD
Minocycline—CASP1—IFN-gamma pathway—AKT1—meningioma	0.00343	0.0058	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—PDGFB—meningioma	0.00341	0.00577	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—PLAU—meningioma	0.00328	0.00555	CbGpPWpGaD
Minocycline—CYCS—Intrinsic Pathway for Apoptosis—AKT1—meningioma	0.00324	0.00548	CbGpPWpGaD
Minocycline—ALOX5—brain—meningioma	0.00317	0.00776	CbGeAlD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—TP53—meningioma	0.0031	0.00524	CbGpPWpGaD
Minocycline—CASP3—Intrinsic Pathway for Apoptosis—TP53—meningioma	0.0031	0.00524	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—PLAU—meningioma	0.00309	0.00523	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—PLAU—meningioma	0.00306	0.00517	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—HES1—meningioma	0.003	0.00507	CbGpPWpGaD
Minocycline—VEGFA—Beta1 integrin cell surface interactions—PLAU—meningioma	0.00298	0.00505	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CTSL—meningioma	0.00281	0.00475	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—ERBB2—meningioma	0.0028	0.00473	CbGpPWpGaD
Minocycline—CASP3—FAS (CD95) signaling pathway—AKT1—meningioma	0.00279	0.00472	CbGpPWpGaD
Minocycline—CASP3—Integrated Cancer Pathway—TP53—meningioma	0.00275	0.00466	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—HES1—meningioma	0.00271	0.00459	CbGpPWpGaD
Minocycline—CYCS—Ceramide signaling pathway—AKT1—meningioma	0.00269	0.00454	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—PDGFB—meningioma	0.00264	0.00446	CbGpPWpGaD
Minocycline—MMP9—Angiogenesis—AKT1—meningioma	0.00262	0.00443	CbGpPWpGaD
Minocycline—CASP3—Intrinsic Pathway for Apoptosis—AKT1—meningioma	0.00262	0.00442	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00261	0.00442	CbGpPWpGaD
Minocycline—CASP1—Immune System—AP1B1—meningioma	0.00254	0.00429	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—CTSL—meningioma	0.00252	0.00425	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—PDGFB—meningioma	0.00251	0.00425	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—PDGFB—meningioma	0.00242	0.00409	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—AKT1—meningioma	0.00241	0.00408	CbGpPWpGaD
Minocycline—CASP3—Copper homeostasis—TP53—meningioma	0.00241	0.00407	CbGpPWpGaD
Minocycline—CYCS—DNA Damage Response—TP53—meningioma	0.00241	0.00407	CbGpPWpGaD
Minocycline—CYCS—p75(NTR)-mediated signaling—TP53—meningioma	0.00238	0.00403	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TP53—meningioma	0.00238	0.00402	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00235	0.00396	CbGpPWpGaD
Minocycline—CYCS—Caspase Cascade in Apoptosis—AKT1—meningioma	0.00234	0.00396	CbGpPWpGaD
Minocycline—CYCS—miRNA Regulation of DNA Damage Response—TP53—meningioma	0.00233	0.00393	CbGpPWpGaD
Minocycline—CASP3—Integrated Cancer Pathway—AKT1—meningioma	0.00233	0.00393	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—PTEN—meningioma	0.00232	0.00391	CbGpPWpGaD
Minocycline—VEGFA—Angiogenesis—AKT1—meningioma	0.00228	0.00385	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—TP53—meningioma	0.00223	0.00377	CbGpPWpGaD
Minocycline—VEGFA—S1P3 pathway—AKT1—meningioma	0.0022	0.00372	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—TP53—meningioma	0.0022	0.00371	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—PDGFB—meningioma	0.00219	0.0037	CbGpPWpGaD
Minocycline—IL1B—IFN-gamma pathway—AKT1—meningioma	0.00214	0.00362	CbGpPWpGaD
Minocycline—SLC22A8—brain—meningioma	0.00214	0.00525	CbGeAlD
Minocycline—CYCS—Alzheimers Disease—TP53—meningioma	0.00214	0.00361	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—AKT1—meningioma	0.00208	0.00352	CbGpPWpGaD
Minocycline—CYCS—mTOR signaling pathway—AKT1—meningioma	0.00208	0.00352	CbGpPWpGaD
Minocycline—CASP3—Copper homeostasis—AKT1—meningioma	0.00203	0.00344	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—meningioma	0.00203	0.00344	CbGpPWpGaD
Minocycline—SLC22A7—Fluoropyrimidine Activity—TP53—meningioma	0.00202	0.00342	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—TP53—meningioma	0.00202	0.00341	CbGpPWpGaD
Minocycline—CYCS—p75(NTR)-mediated signaling—AKT1—meningioma	0.00201	0.0034	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—AKT1—meningioma	0.00201	0.00339	CbGpPWpGaD
Minocycline—VEGFA—VEGFR1 specific signals—AKT1—meningioma	0.00196	0.00331	CbGpPWpGaD
Minocycline—CASP3—DNA Damage Response—TP53—meningioma	0.00194	0.00329	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—PTEN—meningioma	0.00193	0.00327	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—PDGFB—meningioma	0.00193	0.00326	CbGpPWpGaD
Minocycline—CASP3—p75(NTR)-mediated signaling—TP53—meningioma	0.00192	0.00325	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—TP53—meningioma	0.00191	0.00323	CbGpPWpGaD
Minocycline—CASP3—Caspase Cascade in Apoptosis—AKT1—meningioma	0.00189	0.0032	CbGpPWpGaD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—TP53—meningioma	0.00188	0.00318	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—PTEN—meningioma	0.00182	0.00308	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—HES1—meningioma	0.00181	0.00306	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TP53—meningioma	0.0018	0.00305	CbGpPWpGaD
Minocycline—IL1B—IL-1 signaling pathway—AKT1—meningioma	0.00176	0.00298	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TP53—meningioma	0.00172	0.00292	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—AKT1—meningioma	0.00172	0.00291	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—AKT1—meningioma	0.00172	0.0029	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD34—meningioma	0.00171	0.0029	CbGpPWpGaD
Minocycline—MMP9—Plasma membrane estrogen receptor signaling—AKT1—meningioma	0.00171	0.00289	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—AKT1—meningioma	0.0017	0.00288	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—PDGFB—meningioma	0.00168	0.00285	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—AKT1—meningioma	0.00168	0.00284	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—AKT1—meningioma	0.00168	0.00283	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—meningioma	0.00164	0.00278	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALAD—meningioma	0.00164	0.00277	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTSL—meningioma	0.00164	0.00277	CbGpPWpGaD
Minocycline—CASP3—p75(NTR)-mediated signaling—AKT1—meningioma	0.00162	0.00274	CbGpPWpGaD
Minocycline—IL1B—Immune System—AP1B1—meningioma	0.00159	0.00268	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TP53—meningioma	0.00158	0.00267	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—PDGFB—meningioma	0.00158	0.00267	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TP53—meningioma	0.00156	0.00264	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TP53—meningioma	0.00154	0.0026	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—PTEN—meningioma	0.0015	0.00254	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00146	0.00247	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—AKT1—meningioma	0.00139	0.00234	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—AKT1—meningioma	0.00137	0.00232	CbGpPWpGaD
Minocycline—MMP9—FGF signaling pathway—AKT1—meningioma	0.00137	0.00232	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—meningioma	0.00137	0.00231	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PDGFB—meningioma	0.00132	0.00223	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—meningioma	0.00132	0.00223	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PDGFB—meningioma	0.0013	0.00221	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—ERBB2—meningioma	0.00129	0.00219	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—AKT1—meningioma	0.00129	0.00218	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—AKT1—meningioma	0.00129	0.00218	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—meningioma	0.00125	0.00211	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00125	0.00211	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—meningioma	0.00125	0.00211	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—meningioma	0.00124	0.0021	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—meningioma	0.00121	0.00205	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—meningioma	0.0012	0.00202	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—AKT1—meningioma	0.0012	0.00202	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—AKT1—meningioma	0.0012	0.00202	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—AKT1—meningioma	0.00119	0.00201	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00117	0.00198	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—PDGFB—meningioma	0.00117	0.00198	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—AKT1—meningioma	0.00117	0.00197	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—AKT1—meningioma	0.00115	0.00195	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—meningioma	0.00113	0.00191	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—PTEN—meningioma	0.0011	0.00187	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.00107	0.00182	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD34—meningioma	0.00107	0.00181	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—ERBB2—meningioma	0.00106	0.00179	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TSHB—meningioma	0.00105	0.00178	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—AKT1—meningioma	0.00105	0.00178	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—AKT1—meningioma	0.00105	0.00178	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—AKT1—meningioma	0.00104	0.00176	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—meningioma	0.00103	0.00174	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—AKT1—meningioma	0.00103	0.00173	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTSL—meningioma	0.00102	0.00173	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—AKT1—meningioma	0.00101	0.00171	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALAD—meningioma	0.00101	0.00171	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—meningioma	0.00101	0.0017	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—meningioma	0.000989	0.00167	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—AKT1—meningioma	0.000963	0.00163	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—meningioma	0.000943	0.00159	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—PTEN—meningioma	0.000907	0.00153	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—PTEN—meningioma	0.000903	0.00153	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—AKT1—meningioma	0.000901	0.00152	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—ERBB2—meningioma	0.000885	0.0015	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000881	0.00149	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—ERBB2—meningioma	0.000874	0.00148	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—meningioma	0.000868	0.00147	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—AKT1—meningioma	0.000867	0.00147	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—meningioma	0.000854	0.00144	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000851	0.00144	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—AKT1—meningioma	0.000849	0.00144	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.000839	0.00142	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PLAUR—meningioma	0.000834	0.00141	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HES1—meningioma	0.000828	0.0014	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—meningioma	0.000814	0.00138	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—AKT1—meningioma	0.000796	0.00135	CbGpPWpGaD
Minocycline—CASP1—Immune System—PDGFB—meningioma	0.00076	0.00128	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PTEN—meningioma	0.000755	0.00128	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000751	0.00127	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PTEN—meningioma	0.000746	0.00126	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—AKT1—meningioma	0.000721	0.00122	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HES1—meningioma	0.000719	0.00122	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000719	0.00121	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TSHB—meningioma	0.000712	0.0012	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.000688	0.00116	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—ERBB2—meningioma	0.000665	0.00112	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TSHB—meningioma	0.00065	0.0011	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—AKT1—meningioma	0.00065	0.0011	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—AKT1—meningioma	0.000636	0.00108	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—meningioma	0.000619	0.00105	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SMO—meningioma	0.000605	0.00102	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PDGFB—meningioma	0.000603	0.00102	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PLAU—meningioma	0.000585	0.000989	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PGR—meningioma	0.00058	0.000981	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—ERBB2—meningioma	0.000577	0.000976	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—AKT1—meningioma	0.000523	0.000883	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—AKT1—meningioma	0.00052	0.00088	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000513	0.000867	CbGpPWpGaD
Minocycline—CASP1—Immune System—ERBB2—meningioma	0.000509	0.000861	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TSHB—meningioma	0.000494	0.000835	CbGpPWpGaD
Minocycline—IL1B—Immune System—PDGFB—meningioma	0.000475	0.000803	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ERBB2—meningioma	0.000475	0.000802	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—AKT1—meningioma	0.000435	0.000735	CbGpPWpGaD
Minocycline—CASP1—Immune System—PTEN—meningioma	0.000434	0.000734	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000433	0.000732	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—AKT1—meningioma	0.00043	0.000726	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TSHB—meningioma	0.000429	0.000725	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMO—meningioma	0.00042	0.00071	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ERBB2—meningioma	0.000412	0.000697	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PGR—meningioma	0.000403	0.000681	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000398	0.000672	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HES1—meningioma	0.000397	0.000671	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—meningioma	0.000396	0.000669	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000385	0.000651	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMO—meningioma	0.000365	0.000616	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PGR—meningioma	0.00035	0.000591	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PDGFB—meningioma	0.000339	0.000573	CbGpPWpGaD
Minocycline—IL1B—Immune System—ERBB2—meningioma	0.000318	0.000538	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTEN—meningioma	0.000287	0.000486	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HES1—meningioma	0.000275	0.000465	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTEN—meningioma	0.000271	0.000459	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT1—meningioma	0.00025	0.000423	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HES1—meningioma	0.000239	0.000404	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDGFB—meningioma	0.000236	0.000398	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—meningioma	0.000235	0.000398	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT1—meningioma	0.000233	0.000394	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ERBB2—meningioma	0.000227	0.000384	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDGFB—meningioma	0.000204	0.000346	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT1—meningioma	0.000202	0.000342	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT1—meningioma	0.000199	0.000336	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTEN—meningioma	0.000194	0.000328	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTEN—meningioma	0.000177	0.000299	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKT1—meningioma	0.000166	0.00028	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ERBB2—meningioma	0.000158	0.000267	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT1—meningioma	0.000156	0.000264	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ERBB2—meningioma	0.000137	0.000232	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTEN—meningioma	0.000135	0.000228	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—meningioma	0.000132	0.000224	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTEN—meningioma	0.000117	0.000198	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT1—meningioma	0.000112	0.000189	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKT1—meningioma	0.000102	0.000173	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—meningioma	9.19e-05	0.000155	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—meningioma	7.98e-05	0.000135	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT1—meningioma	7.76e-05	0.000131	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT1—meningioma	6.73e-05	0.000114	CbGpPWpGaD
